Así bajará la Ley de Reducción de la Inflación el costo de la atención de la salud
MIÉRCOLES, 17 de agosto de 2022 (HealthDay News) — El Presidente Joe Biden firmó el martes la Ley de Reducción de la Inflación (Inflation Reduction Act), lo que la convierte en la legislación sobre atención de la salud más significativa que se ha apr…
Learn MoreChange to Diagnosis of Gestational Diabetes Helped Women
THURSDAY, Aug. 18, 2022 (HealthDay News) — Using a lower threshold to diagnose pregnancy-related diabetes does not seem to reduce the risk of having a big baby, on average — but some women do benefit, a new clinical trial suggests.Gestational diabete…
Learn MoreHere’s How the Inflation Reduction Act Will Lower the Cost of Health Care
WEDNESDAY, Aug. 17, 2022 (HealthDay News) — President Joe Biden on Tuesday signed the Inflation Reduction Act into law, making it the most significant health care legislation enacted in more than a decade. How will it affect health care?Millions of A…
Learn MoreMultidose BCG Protects Against COVID-19 in At-Risk Individuals
TUESDAY, Aug. 16, 2022 (HealthDay News) — The multidose Bacillus Calmette-Guerin (BCG) vaccine offers protection against COVID-19 infection among COVID-19-unvaccinated individuals with type 1 diabetes, according to a study published online Aug. 15 …
Learn MoreJanuvia, un medicamento común para la diabetes, podría contener vestigios de un cancerígeno, señala la FDA
VIERNES, 12 de agosto de 2022 (HealthDay News) — Januvia, un popular fármaco para la diabetes, podría contener vestigios de un probable carcinógeno, pero los pacientes deben seguir usando el medicamento, porque dejar de tomarlo podría resultar peligr…
Learn MoreFDA: Common Diabetes Drug Januvia May Contain Traces of Carcinogen
FRIDAY, Aug. 12, 2022 (HealthDay News) — The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administra…
Learn MoreCommon Diabetes Drug Januvia May Contain Traces of Carcinogen, FDA Says
FRIDAY, Aug. 12, 2022 (HealthDay News) – The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administratio…
Learn MoreMachine Learning Algorithm Can Predict Diabetes From ECG
WEDNESDAY, Aug. 10, 2022 (HealthDay News) — A machine learning algorithm can detect diabetes and prediabetes from electrocardiogram (ECG) features, according to a study published online Aug. 9 in BMJ Innovations.
Anoop R. Kulkarni, Ph.D., from In…
Learn MoreSARS-CoV-2 Infection Not Linked to T1DM-Related Autoimmunity
TUESDAY, Aug. 9, 2022 (HealthDay News) — There appears to be no association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and autoimmunity related to type 1 diabetes development in children and adolescents, accordin…
Learn MoreUna proteína en la sangre podría predecir el riesgo futuro de diabetes y cáncer
VIERNES, 5 de agosto de 2022 (HealthDay News) — Los niveles elevados de una proteína específica en la sangre parecen vincularse con un aumento en el riesgo de desarrollar diabetes y morir de cáncer, encuentra un nuevo estudio.Unos niveles altos de pr…
Learn More